Firebrick Pharma Ltd has released a press release.
March 2026 Quarterly Activity Report & Appendix 4C
Earlier from Firebrick Pharma
- Firebrick Secures $1.5 million via Placement
- Trading Halt
- Registration Agreement and Approval of Nasodine in Indonesia
- Appendix 4D & Half-Year Financial Report to 31 December 2025